The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Anti-inflammatory, antibacterial and immunomodulatory treatment in children with symptoms corresponding to the research condition PANS (Pediatric Acute-onset Neuropsychiatric Syndrome): A systematic review
Open accessAbstract
Objective: To assess effects of treatment against a hypothesized neuroinflammation in children with symptoms corresponding to the research condition Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) which is not included in current diagnostic systems. Methods: Systematic literature searches were performed (1998 to June 2020) in PubMed, Embase, the Cochrane Library, CINAHL, PsycInfo, and HTA databases. Inclusion criteria: patients (P) were children (<18 years) with PANS; intervention (I)/comparison (C) was use of, versus no use of, anti-inflammatory, antibacterial or immunomodulating treatments; outcomes (O) were health-related quality of life (HRQL), level of functioning, symptom change, and complications. Results: Four randomised controlled trials (RCTs) and three non-RCTs, including 23 to 98 patients, fulfilled the PICO. HRQL was not investigated in any study. Regarding level of functioning, two RCTs investigated antibiotics (penicillin V, azithromycin) and one RCT investigated immunomodulating treatments (intravenous immunoglobulins (IVIG), plasma exchange). Regarding symptoms, two non-RCTs investigated anti-inflammatory treatment (cyclooxygenase (COX) inhibitors, corticosteroids), two RCTs and one non-RCT investigated antibiotics (penicillin V, azithromycin), and two RCTs investigated immunomodulating treatments (IVIG, plasma exchange). Complications, reported in five studies, were consistent with those listed in the summary of products characteristics (SPC). All studies were assessed to have some or major problems regarding directness, the absence of an established diagnosis contributing to clinical diversity in the studied populations. All studies were assessed to have major risk of bias, including selection and detection biases. Due to clinical and methodological diversity, meta-analyses were not performed. Conclusion: This systematic review reveals very low certainty of evidence of beneficial effects, and moderate certainty of evidence of adverse effects, of anti-inflammatory, antibacterial or immunomodulating treatments in patients with symptoms corresponding to the research condition PANS. Available evidence neither supports nor excludes potential beneficial effects, but supports that such treatment can result in adverse effects. Registration: PROSPERO (CRD42020155714).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A systematic analysis from 2021 of randomized controlled trials for IAE anti-inflammatory, antibacterial, or immunomodulating treatment found very low certainty of evidence in their beneficial effects whereas there was moderate certainty of evidence for adverse effects.50”
From An updated review of pediatric autoimmune neuropsychiatric disorders associated with Streptococcus/pediatric acute-onset neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis: What the allergist should know (2023) · cites this paper as [50]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This suggests there is a need for additional larger, welldesigned studies of well characterized patients with IAE, to determine specific biomarkers that could identify those patients most likely to benefit from these therapies.”
From An updated review of pediatric autoimmune neuropsychiatric disorders associated with Streptococcus/pediatric acute-onset neuropsychiatric syndrome, also known as idiopathic autoimmune encephalitis: What the allergist should know (2023) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Dow, S., Zamkoff, J., Dubbert, B. K., & Lougee, L. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.2.264 · Cited by 1,534
Perlmutter, S. J., Leitman, S. F., Garvey, M. A., Hamburger, S., Feldman, E., Leonard, H. L., & Swedo, S. E. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12297-3 · Cited by 556
Ringold, S., Angeles‐Han, S. T., Beukelman, T., Lovell, D., Cuello, C. A., Becker, M. L., Colbert, R. A., Feldman, B. M., Ferguson, P. J., Gewanter, H., et al. (2019) · Arthritis Care & Research · doi:10.1002/acr.23870 · Cited by 462
E. Swedo, S. (2012) · Pediatrics & Therapeutics · doi:10.4172/2161-0665.1000113 · Cited by 421
Chang, K., Frankovich, J., Cooperstock, M., Cunningham, M. W., Latimer, M. E., Murphy, T. K., Pasternack, M., Thienemann, M., Williams, K., Walter, J., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0084 · Cited by 359
Sydenham's chorea. A model for childhood autoimmune neuropsychiatric disorders
Swedo, S. E. (1994) · JAMA · doi:10.1001/jama.272.22.1788 · Cited by 285
Garvey, M. A., Perlmutter, S. J., Allen, A. J., Hamburger, S., Lougee, L., Leonard, H. L., Witowski, M. E., Dubbert, B., & Swedo, S. E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00020-7 · Cited by 250
Snider, L. A., Lougee, L., Slattery, M., Grant, P., & Swedo, S. E. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.035 · Cited by 237
Adolescent Health Status Measurement: Development of the Child Health and Illness Profile
Starfield, B., Ensminger, M., Riley, A., McGauhey, P., Skinner, A., Kim, S., Bergner, M., Ryan, S., & Green, B. (1993) · Pediatrics · doi:10.1542/peds.91.2.430 · Cited by 225
Treatment of PANDAS and PANS: a systematic review
Sigra, S., Hesselmark, E., & Bejerot, S. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.001 · Cited by 177
Thienemann, M., Murphy, T., Leckman, J., Shaw, R., Williams, K., Kapphahn, C., Frankovich, J., Geller, D., Bernstein, G., Chang, K., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0145 · Cited by 149
Frankovich, J., Thienemann, M., Pearlstein, J. G., Crable, A., Brown, K. D., & Chang, K. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0081 · Cited by 148
Frankovich, J., Swedo, S., Murphy, T., Dale, R. C., Agalliu, D., Williams, K., Daines, M., Hornig, M., Chugani, H., Sanger, T., et al. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0148 · Cited by 139
Williams, K. A., Swedo, S. E., Farmer, C. A., Grantz, H., Grant, P. J., D’Souza, P., Hommer, R., Katsovich, L., King, R. A., & Leckman, J. F. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.06.017 · Cited by 124
Swedo, S. E., Seidlitz, J., Kovacevic, M., Latimer, M. E., Hommer, R., Lougee, L., & Grant, P. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0073 · Cited by 116
Characterization of the pediatric acute-onset neuropsychiatric syndrome phenotype
Murphy, T. K., Patel, P. D., McGuire, J. F., Kennel, A., Mutch, P. J., Parker-Athill, E. C., Hanks, C. E., Lewin, A. B., Storch, E. A., Toufexis, M. D., et al. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0062 · Cited by 110
Cooperstock, M. S., Swedo, S. E., Pasternack, M. S., & Murphy, T. K. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0151 · Cited by 106
Overview of treatment of pediatric acute-onset neuropsychiatric syndrome
Swedo, S. E., Frankovich, J., & Murphy, T. K. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2017.0042 · Cited by 104
Hesselmark, E., & Bejerot, S. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.09.002 · Cited by 75
Brown, K. D., Farmer, C., Freeman, G. M., Spartz, E. J., Farhadian, B., Thienemann, M., & Frankovich, J. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0193 · Cited by 72
Gromark, C., Harris, R. A., Wickström, R., Horne, A., Silverberg-Mörse, M., Serlachius, E., & Mataix‐Cols, D. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0127 · Cited by 71
Toh, S., Gagne, J. J., Rassen, J. A., FIREMAN, B. H., Kulldorff, M., & Brown, J. S. (2013) · Medical Care · doi:10.1097/mlr.0b013e31829b1bb1 · Cited by 69
Brown, K. D., Farmer, C., Farhadian, B., Hernandez, J. D., Thienemann, M., & Frankovich, J. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0139 · Cited by 69
Shimasaki, C., Frye, R. E., Trifiletti, R., Cooperstock, M., Kaplan, G., Melamed, I., Greenberg, R., Katz, A., Fier, E., Kem, D., et al. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2019.577138 · Cited by 61
Child Health Questionnaire Parent Short Form
Landgraf, J. M., Abetz, L. N., & Ware, J. E. (1996) · PsycTESTS Dataset · doi:10.1037/t05758-000 · Cited by 60
Murphy, T. K., Brennan, E. M., Johnco, C., Parker-Athill, E. C., Miladinovic, B., Storch, E. A., & Lewin, A. B. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0190 · Cited by 58
Johnson, M., Fernell, E., Preda, I., Wallin, L., Fasth, A. L., Gillberg, C. I., & Gillberg, C. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(18)30404-8 · Cited by 58
Self-citationFrankovich, J., Leibold, C. M., Farmer, C., Sainani, K. L., Kamalani, G., Farhadian, B., Willett, T. A., Park, J. M., Sidell, D. R., Ahmed, S., et al. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m12091 · Cited by 34
Hesselmark, E., & Bejerot, S. (2019) · BJPsych Open · doi:10.1192/bjo.2019.10 · Cited by 28
Antibiotics for PANDAS? Limited Evidence: Review and Putative Mechanisms of Action
Burchi, E., & Pallanti, S. (2018) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.17r02232 · Cited by 23
Leibold, C. M., Thienemann, M., Farhadian, B., Willett, T. A., & Frankovich, J. (2018) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2018.0029 · Cited by 15
Wallerstedt, S. M., & Hoffmann, M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13206 · Cited by 9
Self-citationWallerstedt, S. M., & Hoffmann, M. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02754-6 · Cited by 4
Self-citation
Cited by
Pediatric Acute-Onset Neuropsychiatric Syndrome: Current Perspectives
Gagliano, A., Carta, A., Tanca, M. G., & Sotgiu, S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s362202 · Cited by 48
Xu, J., Frankovich, J., Liu, R.-J., Thienemann, M., Silverman, M. A., Farhadian, B., Willett, T. A., Manko, C., Columbo, L. A., Leibold, C. M., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.07.044 · Cited by 29
Conti, F., Moratti, M., Leonardi, L., Catelli, A., Bortolamedi, E., Filice, E., Fetta, A., Fabi, M., Facchini, E., Cantarini, M. E., et al. (2023) · Cells · doi:10.3390/cells12192417 · Cited by 30
Ma, M., Masterson, E. E., Gao, J., Karpel, H. C., Chan, A. L., Pooni, R., Sandberg, J. K., Rubesova, E., Farhadian, B., Willett, T. A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.21688 · Cited by 22
Neuroinflammation in Obsessive-Compulsive Disorder
Vreeland, A., Thienemann, M., Cunningham, M. W., Muscal, E., Pittenger, C., & Frankovich, J. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2022.11.004 · Cited by 22
Metadata
- Authors
- Johnson, M., Ehlers, S., Fernell, E., Hajjari, P., Wartenberg, C., & Wallerstedt, S. M.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Kungälvs Sjukhus (SE)
- Corresponding author
- Johnson, Mats
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-07-01
- Volume
- 16
- Issue
- 7
- Pages
- e0253844
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC8248649
- OpenAlex
- W3175116915
- Cited by
- 25
- References
- 36
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 4 · 2021: 2
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Eli Lilly and Company
- Topics
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Kawasaki Disease and Coronary Complications
- Keywords
- pediatric acute-onset neuropsychiatric syndrome, PANS, anti-inflammatory therapy, antibiotic therapy, immunomodulatory therapy, neuroinflammation, children, intravenous immunoglobulin, plasma exchange, antibiotics, penicillin V, azithromycin, corticosteroids, cyclooxygenase inhibitors, health-related quality of life, treatment side effects
- MeSH terms
- Anti-Inflammatory Agents, Anti-Bacterial Agents, Autoimmune Diseases, Child, Combined Modality Therapy, Glucocorticoids, Humans, Immunologic Factors, Obsessive-Compulsive Disorder, Plasma Exchange, Quality of Life, Randomized Controlled Trials as Topic, Immunoglobulins, Intravenous, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.